Neoantigen Cancer Vaccine Market Size and Analysis 2034
The global neoantigen cancer vaccine market was USD 116.74M in 2024 and is set to surge at 69.43% CAGR, reaching USD 22,757.41M by 2034.
Written by
Digital Marketing Executive at Claight Corporation (Expert Market Research), specializing in SEO strategies and campaigns that enhance growth, visibility, and traffic in the healthcare industry.
Responses
Markdown supported · ⌘↵ to post
No responses yet.